Elicio Therapeutics
Stock Forecast, Prediction & Price Target
Elicio Therapeutics Financial Estimates
Elicio Therapeutics Revenue Estimates
Elicio Therapeutics EBITDA Estimates
Elicio Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-26.40M N/A | $-28.20M -6.84% | $-35.19M -24.77% | Avg: $-9.51M Low: $-10.38M High: $-8.61M avg. 72.95% | |||
EBITDA
% change YoY
| $-25.21M N/A | $-23.27M 7.69% | $-32.96M -41.61% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$8.25 N/A | -$9.1 -10.30% | -$6.96 23.51% | Avg: -$3.07 Low: -$3.35 High: -$2.78 avg. 55.89% | |||
Operating Expenses
% change YoY
| $25.47M N/A | $23.73M -6.83% | $34.57M 45.68% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Elicio Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 72.95% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -10.38M, average is -9.51M and high is -8.61M.
What is Elicio Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Elicio Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 55.89% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.35, average is -$3.07 and high is $-2.78.